ALEC
Price:
$4.85
Market Cap:
$472.01M
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase I clinical trial for the treatment of Alzheimer's...[Read more]
Industry
Biotechnology
IPO Date
2019-02-07
Stock Exchange
NASDAQ
Ticker
ALEC
According to Alector, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.68. This represents a change of -22.80% compared to the average of -3.47 of the last 4 quarters.
The mean historical PE Ratio of Alector, Inc. over the last ten years is -25.02. The current -2.68 PE Ratio has changed 971.14% with respect to the historical average. Over the past ten years (40 quarters), ALEC's PE Ratio was at its highest in in the June 2023 quarter at 91.24. The PE Ratio was at its lowest in in the March 2018 quarter at -27.32.
Average
-25.02
Median
-17.10
Minimum
-61.02
Maximum
-5.12
Discovering the peaks and valleys of Alector, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 821.86%
Maximum Annual PE Ratio = -5.12
Minimum Annual Increase = -90.37%
Minimum Annual PE Ratio = -61.02
Year | PE Ratio | Change |
---|---|---|
2023 | -5.12 | -10.25% |
2022 | -5.71 | -90.37% |
2021 | -59.28 | 821.86% |
2020 | -6.43 | -39.66% |
2019 | -10.66 | -54.75% |
2018 | -23.55 | -17.03% |
2017 | -28.39 | -53.48% |
The current PE Ratio of Alector, Inc. (ALEC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-23.37
5-year avg
-17.44
10-year avg
-25.02
Alector, Inc.’s PE Ratio is less than Passage Bio, Inc. (-0.57), greater than Black Diamond Therapeutics, Inc. (-3.70), less than TCR2 Therapeutics Inc. (-0.44), greater than Harpoon Therapeutics, Inc. (-2.94), greater than Revolution Medicines, Inc. (-13.31), less than Atreca, Inc. (-0.04), greater than Stoke Therapeutics, Inc. (-7.92), less than Homology Medicines, Inc. (-0.01), greater than Monte Rosa Therapeutics, Inc. (-3.11), less than Cabaletta Bio, Inc. (-2.34), greater than Larimar Therapeutics, Inc. (-8.80),
Company | PE Ratio | Market cap |
---|---|---|
-0.57 | $43.48M | |
-3.70 | $305.13M | |
-0.44 | $58.11M | |
-2.94 | $865.08M | |
-13.31 | $6.99B | |
-0.04 | $3.57M | |
-7.92 | $773.92M | |
-0.01 | $3.02M | |
-3.11 | $349.21M | |
-2.34 | $208.10M | |
-8.80 | $513.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alector, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alector, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Alector, Inc.'s PE Ratio?
How is the PE Ratio calculated for Alector, Inc. (ALEC)?
What is the highest PE Ratio for Alector, Inc. (ALEC)?
What is the 3-year average PE Ratio for Alector, Inc. (ALEC)?
What is the 5-year average PE Ratio for Alector, Inc. (ALEC)?
How does the current PE Ratio for Alector, Inc. (ALEC) compare to its historical average?